What does rSPI stand for?
RespireRx Pharmaceuticals Inc. (RSPI) (“RespireRx” or the “Company”), a leader in the research and development of cannabinoids for the treatment of sleep-related breathing disorders, announces that it has sent a formal notice to the Board of Directors of Therapix Biosciences Ltd. (Therapix).
Where can I buy shares of RSPI?
Shares of RSPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Where can I buy RespireRx Pharmaceuticals (RSPI)?
Shares of RSPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is RespireRx Pharmaceuticals' stock price today?
Will RSPI outperform or underperform the S&P 500 over the long term?
MarketBeat's community ratings are surveys of what our community members think about RespireRx Pharmaceuticals and other stocks. Vote “Outperform” if you believe RSPI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RSPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
How has RespireRx Pharmaceuticals' stock price performed in 2022?
RespireRx Pharmaceuticals' stock was trading at $0.0117 at the beginning of the year. Since then, RSPI stock has decreased by 48.7% and is now trad...
How were RespireRx Pharmaceuticals' earnings last quarter?
RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI) posted its quarterly earnings data on Wednesday, August, 19th. The company reported ($0.01) EPS for t...
Who are RespireRx Pharmaceuticals' key executives?
RespireRx Pharmaceuticals' management team includes the following people: Dr. Arnold S. Lippa Ph.D. , Exec. Chairman, Interim Pres, Interim CEO &...
Who are some of RespireRx Pharmaceuticals' key competitors?
Some companies that are related to RespireRx Pharmaceuticals include NTN Buzztime (NTN) , Global Future City (FTCY) , Earth Science Tech (ETST)...
What other stocks do shareholders of RespireRx Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other RespireRx Pharmaceuticals investors own include American B...
What is RespireRx Pharmaceuticals' stock symbol?
RespireRx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RSPI."
How do I buy shares of RespireRx Pharmaceuticals?
Shares of RSPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is RespireRx Pharmaceuticals' stock price today?
One share of RSPI stock can currently be purchased for approximately $0.01.
How much money does RespireRx Pharmaceuticals make?
RespireRx Pharmaceuticals (OTCMKTS:RSPI) has a market capitalization of $675.42 thousand.
What is the ticker symbol for Respirerx?
What is the official website for Respirerx?
RespireRx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RSPI."
What is MarketBeat community ratings?
The official website for RespireRx Pharmaceuticals is www.respirerx.com.
Who is Respirerx Pharmaceuticals?
MarketBeat's community ratings are surveys of what our community members think about RespireRx Pharmaceuticals and other stocks. Vote “Outperform” if you believe RSPI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RSPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Is there enough data for Respirerx?
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
Does Respirerx pay dividends?
There is not enough analysis data for RespireRx Pharmaceuticals.
Is a stock that moves a lot during the day considered high risk?
RespireRx Pharmaceuticals does not currently pay a dividend.
Is RespireRx Pharmaceuticals Inc. stock A Buy?
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0049 between high and low, or 24.50%. For the last week the stock has had a daily average volatility of 31.70% .
What is Respirerx Pharmaceuticals?
RespireRx Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
What are the different grades for stocks?
is a biopharmaceutical company which focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain- mediated breathing disorders. The company's drug platforms comprises of ampakines for positive allosteric modulators of AMPA glutamate receptors and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting as well as for anorexia. RespireRx Pharmaceuticals Inc. is based in Glen Rock, New Jersey.
